The value of neuroscience strategies to accelerate progress in psychological treatment research

Canadian Journal of Psychiatry

Volumn 51, Issue 13, 2006, Pages 810-822

  Moras, Karla ^a  

^a NONE   (United States)

Author keywords

Affective neuroscience; Behavioural neuroscience; Causal mechanisms; Cognitive neuroscience; Mechanisms of change; Neurobehavioural treatments; Psychological treatment research

Indexed keywords

PLACEBO;

BEHAVIORAL RESEARCH; CLINICAL RESEARCH; CLINICAL TRIAL; COGNITION; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; DRUG DEPENDENCE; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; NEUROIMAGING; NEUROPSYCHOLOGY; NEUROSCIENCE; NEUROTRANSMISSION; OBSESSIVE COMPULSIVE DISORDER; POSTTRAUMATIC STRESS DISORDER; PSYCHOANALYSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; TRANSFERENCE; TREATMENT PLANNING; BRAIN; MEDICAL RESEARCH; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; STANDARD;

BIOMEDICAL RESEARCH; BRAIN; HUMANS; MAGNETIC RESONANCE IMAGING; MENTAL DISORDERS; NEUROSCIENCES;

EID: 33846944731     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674370605101303     Document Type: Review

References (99)

1. Davidson RJ, Pizzagalli D, Nitschke JB, Putnam K. Depression: perspectives from affective neuroscience. Annu Rev Psychol 2002;53:545-74.
2. Lane RD, Nadel L. Cognitive neuroscience of emotion. New York (NY): Oxford University Press; 2000.
3. Moras K. Research in psychotherapy. In Hersen M, Sledge W, editors. Encyclopedia of psychotherapy. Volume 2. New York (NY): Academic Press; 2002. p 525-45.
4. Moras K. Extending the scientific foundation of psychotherapy research. Presidential address presented at the Conference of the Society for Psychotherapy Research; 2003 June; Weimar (DE).
5. Chambless DL, Baker MJ, Baucom DH, Beutler LE, Calhoun KS, Crits-Christoph P, and others. Update on empirically validated therapies II. Clin Psychol 1998;51: 3-16.
6. Chambless DL, Ollendick TH. Empirically supported psychological interventions: controversies and evidence. Annu Rev Psychol 2001;52:685-716.
7. Task Force on Promotion and Dissemination of Psychological Procedures. Training in and dissemination of empirically-validated psychological treatments: report and recommendations. Clin Psychol 1995;48:3-24.
8. Barlow DH, Gorman JM, Shear MK, Woods SW. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. JAMA 2000;283:2529-36.
9. Casacalenda N, Perry JC, Looper K. Remission in major depressive episode: a comparison of pharmacotherapy, pspychotherapy, and control conditions. Am J Psychiatry 2002;159:1354-60.
10. DeMaat S, Dekker J, Schoevers R, DeJonghe F. Relative efficacy of psychotherapy and pharmacotherapy in the treatment of depression: a meta-analysis. Psychotherapy Res 2006;16:566-78.
11. Elkin I, Shea T, Watkins JT, Imber SD, Sotsky SM, Collins JF, and others. National Institute of Mental Health Treatment of Depression Collaborative Research Program: general effectiveness of treatments. Arch Gen Psychiatry 1989;46:971-82.
12. Insel T. Beyond efficacy: the STAR*D trial. Am J Psychiatry 2006;163:5-7.
13. Joyce AS, Wolfaardt U, Sribney C, Aylwin AS. Psychotherapy research at the start of the 21st century: the persistence of the art versus science controversy. Can J Psychiatry 2006;51:795-809.
14. Smith ML, Glass GV. Meta-analysis of psychotherapy outcome studies. Am Psychol 1977;32:752-60.
15. Elkin I, Parloff MB, Hadley SW, Autry JH. NIMH Treatment of Depression Collaborative Research Program. Background and research plan. Arch Gen Psychiatry 1985;42:305-16.
16. Luborsky L, DeRubeis, RJ. The use of psychotherapy treatment manuals: a small revolution in psychotherapy research style. Clin Psychol Rev 1984;4:5-14.
17. Wilson GT. Manual-based treatments: the clinical application of research findings. Behav Res Ther 1996;34:295-314.
18. Barlow DH. Psychological treatments. Am Psychol 2004;59:869-78.
19. Hollon SD, DeRubeis RJ, Shelton RC, Amsterdam JD, Salomon RM, O'Reardon JP, and others. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Arch Gen Psychiatry 2005;62:417-22.
20. Baxter, LR Jr, Schwartz JM, Bergman KS, Szuba MP, Guze BH, Mazziotta JC, and others. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 1992;49:681-89.
21. Schwartz J M. Neuroanatomical aspects of cognitive-behavioural therapy response in obsessive-compulsive disorder. Br J Psychiatry 1998;173(Suppl 35):38-44.
22. Martin SD, Martin E, Rai SS, Richardson MA, Royall R. Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: preliminary findings. Arch Gen Psychiatry 2001;58:641-8.
23. Davidson RJ, Kabat-Zinn J, Schumacher J, Rosenkranz M, Muller D, Santorelli,SF, and others. Alterations in brain and immune function produced by mindfulness meditation. Psychosom Med 2003;65:564-70.
24. Paquette V, Levesque J, Mensour B, Leroux JM, Beaudoin G, Bourgouin P, Beauregard M. "Change the mind and you change the brain:" effects of cognitive-behavioral therapy on the neural correlates of spider phobia. Neuroimage 2003;18:401-9.
25. Goldapple K, Segal Z, Garson C, Lau M, Bieling P, Kennedy S, and others. Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiatry 2004;61(1):34-41.
26. Strauman TJ, Merrill KA. The basic science/clinical science interface and treatment development. Clin Psychol Sci Prac 2004;11;263-6.
27. Andreasen NC. Linking mind and brain in the study of mental illnesses: a project for a scientific psychopathology. Science 1997; 275:1586-93.
28. Mayberg HS, Liotti M, Brannan SK, McGinnis S, Mahurin RK, Jerabek PA, and others. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 1999;156:675-82.
29. Mayberg HS, Brannan SK, Tekell JL, Silva JA, Mahurin RK, McGinnis S, and others. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry 2000;48:830-43.
30. Kalivas PW, Volkow ND. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 2005;162:1403-13.
31. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive therapy of depression. New York (NY): Guilford Press; 1979.
32. Beck JS. Cognitive therapy: basics and beyond. New York (NY): Guilford Press; 1995.
33. Moras K. Treatment resistant depression: clinical and research perspectives on patient features and alternative treatments. Panel session at the Conference of the Society for Psychotherapy Research; 2000 June; Chicago (IL).
34. Siegle GJ, Ghinassi F, Thase ME. Neurobehavioral therapies in the 21st century: summary of an emerging field and an extended example of cognitive control training for depression, Cogn Ther Res March 2007. Forthcoming.
35. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Text revision. Washington (DC): American Psychiatric Association Press; 2000.
36. Kiesler DJ. Beyond the disease model of mental disorders. Westport (CT): Praeger; 1999.
37. Krueger RF, Watson D, Barlow DH. Introduction to the special section: toward a dimensionally based taxonomy of psychopathology. J Abnorm Psychol 2005;114:491-3.
38. Watson D. Rethinking the mood and anxiety disorders: a quantitative hierarchical model for DSM-V. J Abnorm Psychol 2005;114:522-36.
39. Barron JW. Making diagnosis meaningful: enhancing evaluation and treatment of psychological disorders. Washington (DC): American Psychological Association; 1998.
40. Widiger TA, Clark LA. Toward DSM-V and the classification of psychopathology. Psychol Bull 2000;126:946-63.
41. Davidson RJ. Well-being and affective style: neural substrates and biobehavioral correlates. Phil Trans R Soc Lond B Biol Sci 2004;359:1395-411.
42. Rogers CR. Client-centered counselling. Boston (MA): Houghton-Mifflin; 1951.
43. Kiesler D J. The process of psychotherapy: empirical foundations and systems of analysis. Chicago (IL): Aldine Publishing Company; 1973.
44. Doss BD. Changing the way we study change in psychotherapy. Clin Psychol Sci Prac 2004;11:368-86.
45. Kraemer HC, Wilson GT, Fairburn CG, Agras WS. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry 2002;59:877-83.
46. Piper WE, Joyce AS, McCallum M, Azim H F A. Interpretive and supportive forms of psychotherapy and patient personality variables. J Consult Clin Psychol 1998;66:558-67.
47. Joyce AS, Ogrodniczuk JS, Piper WE, McCallum, M. The alliance as mediator of expectancy effects in short-term individual therapy. J Consult Clin Psychol 2003;71:672-9.
48. DeRubeis R J, Brotman MA, Gibbons CJ. A conceptual and methodological analysis of the nonspecifics argument. Clin Psychol Sci Prac 2005;12:174-83.
49. Kazdin AE. Treatment outcomes, common factors, and continued neglect of mechanisms of change. Clin Psychol Sci Prac 2005;12:184-8.
50. Kazdin AE. Mechanisms of change in psychotherapy: advances, breakthroughs, and cutting-edge research (do not yet exist). In: Bootzin RR, McKnight PE, editors. Strengthening research methodology: psychological measurement and evaluation. Washington (DC): American Psychological Association; 2006. p 77-101.
51. Horvath AO, Symonds BD. Relation between working alliance and outcome in psychotherapy: a meta-analysis. J Counseling Psychology 1991;38:139-49.
52. Platt JD. Strong inference. Science 1964;146:347-53.
53. Fava M, Davidson KG. Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am 1996;19:179-200.
54. Amsterdam JD, Hornig M, Nierenberg AA, editors. Treatment-resistant mood disorders. Cambridge (UK): Cambridge U Press; 2001.
55. Greenberg LS, Pinsof WM, editors. The psychotherapeutic process: a research handbook. New York (NY): Guilford Press; 1986.
56. Orlinsky DE, Howard KI. The relation of process to outcome in psychotherapy. In: Garfield S, Bergin A, editors., Handbook of psychotherapy and behavior change. 2nd ed. New York (NY): John Wiley; 1978. p 283-329.
57. Orlinsky DE, Rønnestad MH, Willutzki U. Fifty years of psychotherapy process-outcome research: continuity and change. In: Lambert M, editor. Bergin and Garfield's handbook of psychotherapy and behavior change. 5th ed. New York (NY): John Wiley; 2004. p 307-89.
58. Kazdin AE. Developing a research agenda for child and adolescent psychotherapy. Arch Gen Psychiatry 2000;57:829-35.
59. Marks IM. The maturing of therapy: some brief psychotherapies help anxiety/depressive disorders but mechanisms of action are unclear. Br J Psychiatry 2002;180:200-4.
60. Craighead WE, Sheets ES, Bjornsson AS. Specificity and nonspecificity in psychotherapy. Clin Psychol: Sci Prac 2005;12:189-93.
61. Wampold BE. The great psychotherapy debate: models, methods, and findings. Mahwah (NJ): Lawrence Erlbaum; 2001.
62. Frank J. Persuasion and healing. Baltimore (MD): Johns Hopkins University Press; 1961.
63. Foa EB, Emmelkamp P MG. Failures in behavior therapy. New York (NY): John Wiley & Sons; 1983.
64. Strupp HH, Hadley SW, Gomes-Schwartz B. Psychotherapy for better or worse: the problem of negative effects. New York (NY): Jason Aronson; 1977.
65. Orlinsky DE. Comments on the state of psychotherapy research (as I see it). North American Society for Psychotherapy Research Newsletter January, 2006. p. 2-3. Available: www.naspr.org/. Accessed 2006 Mar 5.
66. Phillips A. A mind is a terrible thing to measure. New York Times 2006 Feb.26. Available:www.nytimes.com/2006/02/26/opinion/26phillips.html?ex= 1298610000&en=f73dddb60a11faa3& ei=5088&partner=rssnyt&emc=rss. Accessed 2006 Aug 17.
67. Etkin A, Pittenger C, Polan HJ, Kandel ER. Toward a neurobiology of psychotherapy: basic science and clinical applications. J Neuropsychiatry Clin Neurosci 2005;17:145-58.
68. Kandel ER. Psychotherapy and the single synapse: the impact of psychiatric thought on neurobiological research. J Neuropsychiatry Clin Neurosci 1979;13:290-300.
69. Tryon WW. Possible mechanisms for why desensitization and exposure therapy work. Clin Psychol Rev 2005;25:67-95.
70. Brewin CR. A cognitive neuroscience account of posttraumatic stress disorder and its treatment. Behav Res Ther 2001;39:371-93.
71. Westen D. Implications of developments in cognitive neuroscience for psychoanalytic psychotherapy. Harv Rev Psychiatry 2002;10:369-73.
72. LeDoux J. Synaptic self: how our brains become who we are. New York (NY): Viking Penguin; 2002.
73. Deckersbach T, Dougherty DD, Rauch SL. Functional imaging of mood and anxiety disorders. J Neuroimaging 2006;16(1):1-10.
74. Meyer-Lindenberg A, Poline JB, Kohn PD, Holt JL, Egan MF, Weinberger DR, and others. Evidence for abnormal cortical functional connectivity during working memory in schizophrenia. Am J Psychiatry 2001;158:1809-17.
75. Mataix-Cols D, Wooderson S, Lawrence N, Brammer MJ, Speckens A, Phillips ML. Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. Arch Gen Psychiatry 2004:61;564-76.
76. Schwartz JM, Stoessel PW, Baxter Jr, LR, Martin KM, Phelps ME. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 1996;53:109-13.
77. Schwartz JM, Beyette B. Brain lock: free yourself from obsessive-compulsive behavior: a four-step self-treatment method tochange your brain chemistry. 1st ed. New York (NY): Regan Books; 1996.
78. Schwartz, JM. Neuroanatomical aspects of cognitive-behavioural therapy response in obsessive-compulsive disorder: an evolving perspective on brain and behaviour. Br J Psychiatry 1998;173(Suppl 35):38-44.
79. Maser JD, Cloninger CR, editors. Comorbidity of mood and anxiety disorders. Washington (DC): American Psychiatric Press; 1990.
80. Rosen GM, Davison GC. Psychology should list empirically supported principles of change (ESPs) and not credential trademarked therapies or other treatment packages. Behav Modif 2003;27:300-12.
81. Mayberg HS. Limbic-cortical dysregulation: a proposed model of depression. J Neuropsychiatry Clin Neurosci 1997;9:471-81.
82. Seminowicz DA, Mayberg HS, McIntosh AR, Goldapple K, Kennedy S, Segal Z, and others. Limbic-frontal circuitry in major depression: a path modeling metanalysis. Neuroimage 2004;22:409-18.
83. Mayberg HS, Silva JA, Brannan SK, Tekell JL, Manhurin RK, McGinnis S, and others. The functional neuroanatomy of the placebo effect. Am J Psychiatry 2002;159:728-37.
84. Simons AD, Garfield SL, Murphy GE. The process of change in cognitive therapy and pharmacotherapy for depression. changes in mood and cognition. Arch Gen Psychiatry 1984;41(1):45-51.
85. Schatzberg AF, Kraemer HC. Use of placebo control groups in evaluating efficacy of treatment of unipolar major depression. Biol Psychiatry 2000;47:736-44.
86. Baskin TW, Tierney SC, Minami T, Wampold BE. Establishing specificity in psychotherapy: a meta-analysis of structural equivalence of placebo controls. J Consult Clin Psychol 2003;71:973-79.
87. Horvath P. Placebos and common factors in two decades of psychotherapy research. Psychol Bul 1988;104:214-25.
88. Benedetti F, Mayberg HS, Wager TD, Stohler CS, Zubieta J. Neurobiological mechanisms of the placebo effect. J Neurosci 2005;25:10390-402.
89. Wampold BE, Minami T, Tierney SC, Baskin TW, Bhati KS. The placebo is powerful: estimating placebo effects in medicine and psychotherapy from randomized clinical trials. J Clin Psychol 2005;61:835-54.
90. Wagar TD. The neural bases of placebo effects in pain. Curr Direct Psychol Sci 2005;14:175-9.
91. Parloff MB. Placebo controls in psychotherapy research: a sine qua non or a placebo for research problems? J Consult Clin Psychol 1986;54(1):79-87.
92. Borkovec TD, Sibrava NJ. Problems with the use of placebo conditions in psychotherapy research, suggested alternatives, and some strategies for the pursuit of the placebo phenomenon. J Clin Psychol 2005;61:805-18.
93. Eysenck HJ. The effects of psychotherapy: an evaluation. J Consult Clin Psychol 1952;16:319-24.
94. Teasdale JD, Segal ZV, Williams JMG, Ridgeway VA, Soulsby JM, Lau MA. Prevention of relapse/recurrent in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol 2000;68:615-23.
95. Segal ZV, Teasdale J, Williams JMG. Mindfulness-based cognitive therapy for depression: a new approach to preventing relapse. New York (NY): Guilford Press; 2001.
96. Schaefer SM, Jackson DC, Davidson RJ, Aguirre GK, Kimberg DY, Thompson-Schill SL. Modulation of amygdalar activity by the conscious regulation of negative emotion. J Cogn Neurosci 2002;14:913-21.
97. Ochsner KN, Ray RD, Cooper JC, Robertson ER, Chopra S, Gabrieli JDE, and others. For better or worse: neural systems supporting the cognitive down- and up-regulation of negative emotion. Neuroimage 2004;23:483-99.
98. Wells A. Emotional disorders and metacognition: innovative cognitive therapy. New York (NY): John Wiley & Sons; 2000.
99. Norcross JC, Kohout JL, Wicherski M. Graduate study in psychology: 1971 to 2004. Am Psychol 2005;60:959-75.